Ecteinascidin 743 Interferes with the Activity of EWS-FLI1 in Ewing Sarcoma Cells

ET-743 (trabectedin; Yondelis) is approved in Europe for the treatment of soft tissue sarcomas. Emerging phase 1 and 2 clinical data have shown high response rates in myxoid liposarcoma in part owing to the inhibition of the FUS-CHOP transcription factor. In this report, we show that modulation of s...

詳細記述

保存先:
書誌詳細
主要な著者: Grohar, Patrick J, Griffin, Laurie B, Yeung, Choh, Chen, Qing-Rong, Pommier, Yves, Khanna, Chand, Khan, Javed, Helman, Lee J
フォーマット: Artigo
言語:Inglês
出版事項: Neoplasia Press Inc. 2011
主題:
Research Article
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC3033593/
https://ncbi.nlm.nih.gov/pubmed/21403840
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料